These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16007659)

  • 1. Corticobasal degeneration and Parkinson's disease assessed by HmPaO SPECT: the utility of factorial discriminant analysis.
    Kreisler A; Defebvre L; Lecouffe P; Duhamel A; Charpentier P; Steinling M; Destée A
    Mov Disord; 2005 Nov; 20(11):1431-8. PubMed ID: 16007659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification of parkinsonian syndromes via factorial discriminant analysis of brain SPECT data].
    Kreisler A; Defebvre L; Duhamel A; Lecouffe P; Dujardin K; Steinling M; Pasquier F; Destée A
    Rev Neurol (Paris); 2009 May; 165(5):440-8. PubMed ID: 19150099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data.
    Charpentier P; Lavenu I; Defebvre L; Duhamel A; Lecouffe P; Pasquier F; Steinling M
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):661-3. PubMed ID: 11032624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls.
    Markus HS; Lees AJ; Lennox G; Marsden CD; Costa DC
    Mov Disord; 1995 Mar; 10(2):179-87. PubMed ID: 7753060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
    Saur HB; Bartenstein P; Schober O; Oberwittler C; Lerch H; Masur H
    Nuklearmedizin; 1994 Oct; 33(5):184-8. PubMed ID: 7997375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood flow in corticobasal degeneration.
    Okuda B; Tachibana H
    Mov Disord; 1995 Nov; 10(6):803. PubMed ID: 8750006
    [No Abstract]   [Full Text] [Related]  

  • 8. Technetium-99m HMPAO imaging in patients with basal ganglia disease.
    Smith FW; Gemmell HG; Sharp PF; Besson JA
    Br J Radiol; 1988 Oct; 61(730):914-20. PubMed ID: 2973362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB; Jones DW; Coppola R; Hyde TM; Lee KS; Gorey J; Weinberger DR
    J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
    Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I
    J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping.
    Hossain AK; Murata Y; Zhang L; Taura S; Saitoh Y; Mizusawa H; Oda K; Matsushima E; Okubo Y; Shibuya H
    Mov Disord; 2003 Jun; 18(6):697-703. PubMed ID: 12784276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.
    Hu WT; Rippon GW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Josephs KA
    Mov Disord; 2009 Jul; 24(9):1375-9. PubMed ID: 19425061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease.
    Liu RS; Lin KN; Wang SJ; Shan DE; Fuh JL; Yeh SH; Liu HC
    Nucl Med Commun; 1992 Oct; 13(10):744-8. PubMed ID: 1491839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of non-presynaptic SPECT tracer methods in Parkinson's disease.
    Leenders KL
    Mov Disord; 2003 Oct; 18 Suppl 7():S39-42. PubMed ID: 14531045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography.
    Hayashida K; Fukuchi K; Inubushi M; Fukushima K; Imakita S; Kimura K
    J Nucl Med; 2001 Jun; 42(6):859-63. PubMed ID: 11390548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inferior frontal region hypoperfusion in Parkinson disease with dementia].
    Ochudło S; Opala G; Jasińska-Myga B; Siuda J; Nowak S
    Neurol Neurochir Pol; 2003; 37 Suppl 5():133-44. PubMed ID: 15098340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions.
    Smith FW; Besson JA; Gemmell HG; Sharp PF
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
    Chang CC; Liu JS; Chang YY; Chang WN; Chen SS; Lee CH
    Eur J Neurol; 2008 Jan; 15(1):61-5. PubMed ID: 18042240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.